[Remote] Medical Science Liaison - Cardiometabolic at Eli Lilly and Company

Poland

Apply Now

Not SpecifiedCompensation

Junior (1 to 2 years)Experience Level

Full TimeJob Type

UnknownVisa

Pharmaceuticals, HealthcareIndustries

Requirements

Candidates must possess a minimum of 5 years of experience in the pharmaceutical industry, holding a University degree or PhD in Health Sciences or a medically related field, and demonstrate proficiency in English. Knowledge and experience in Diabetes would be an advantage.

Responsibilities

The Medical Science Liaison will demonstrate deep scientific knowledge, possessing detailed scientific and clinical knowledge of TAs, disease states, and therapeutic options, effectively communicating complex scientific concepts and information to engage with scientific experts and foster a two-way scientific dialogue. They will identify opportunities for research collaborations, support medical initiatives, share unique insights based on interactions with scientific experts, and contribute to improving patient outcomes by providing needed information. The role involves territory ownership, strategic planning, implementing ML core activities, evaluating plan implementation, demonstrating strategic analysis, and delivering best-in-class customer experiences while collaborating effectively with cross-functional teams and exhibiting leadership and influencing skills.

Skills

Scientific knowledge

Clinical knowledge

Communication skills

Scientific exchange

Research collaboration

Medical initiatives

Disease states

Therapeutic options

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Indianapolis, IndianaHeadquarters

1876Year Founded

$1,180.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.

Potential construction delays in Indiana could affect GLP-1 drug production timelines.

Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.

Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.

FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.

Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.

Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI

Try Jobo Free